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SUMMARY – Th e morphological spectrum of gallbladder carcinoma is broad and variable. 
Most of these tumors are tubular adenocarcinomas. Th ere are some tumors with unusual morpho-
logy that may be diffi  cult to classify due to their rarity. One of such tumors is the signet-ring cell 
carcinoma, which is a highly aggressive, mucin producing variant of gallbladder adenocarcinoma 
predominantly or exclusively composed of signet-ring cells. Histologically, these tumors are similar 
to their counterparts in other organs such as stomach, colon and breast, and should not be misin-
terpreted as metastatic carcinoma from one of these primary sites. Th e literature about this variant 
of carcinoma is sparse and little is known about it. We found only three cases of signet-ring cell 
carcinoma of the gallbladder previously reported. We present the case of an 86-year-old woman 
with signet-ring cell carcinoma of the gallbladder and discuss the potential diagnostic dilemmas 
and pitfalls.
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Introduction
Th e morphological spectrum of gallbladder car-
cinoma is broad and variable. Most of these tumors 
are tubular adenocarcinomas. Th ere are some tumors 
with unusual morphology that may be diffi  cult to 
classify due to their rarity1. One of such tumors is the 
signet-ring cell carcinoma (SRCC), which is a highly 
aggressive, mucin producing variant of gallbladder 
adenocarcinoma predominantly or exclusively com-
posed of signet-ring cells2-4. Histologically, these tu-
mors are similar to their counterparts in other organs 
such as stomach, colon and breast, and should not be 
misinterpreted as metastatic carcinoma from one of 
these primary sites5-7.
To our knowledge, only two cases of gallbladder 
SRCC have been reported in English literature2,3 and 
one case in Japanese4 literature, and little is known 
about this histological variant. 
Herein we present a case of gallbladder SRCC in 
an 86-year-old female.
Case Report
An 86-year-old female with diagnosed hyperten-
sion, Parkinson syndrome and bilateral coxarthrosis 
presented with a sudden onset of icterus and a history 
of intermittent abdominal pain over the course of one 
year. Laboratory tests showed anemia and elevated 
bilirubin, aspartate aminotransferase, alanine ami-
notransferase, lactate dehydrogenase, amylase, urea 
and creatinine. She was admitted to the hospital for 
suspicion of acute biliary pancreatitis. 
Abdominal ultrasonography revealed a normal sized 
gallbladder with a gallstone, as well as multiple liver 
Ivana Pavić et al.  Signet-ring cell carcinoma of the gallbladder 
160 Acta Clin Croat,  Vol. 49,  No. 2,  2010
nodules measuring up to 2 cm in diameter. Ductus cho-
ledochus was dilated and measured up to 1 cm in diam-
eter. Contrast-enhanced endoscopy was not performed 
because the patient had a medical history of allergic reac-
tions. Instead, explorative laparotomy was suggested. 
Laparotomy revealed a normal sized gallbladder 
with thickened wall and fi brous serous adhesions. On 
the surface of the liver there were multiple metasta-
ses measuring up to 2 cm in greatest diameter. Some 
enlarged regional lymph nodes were also present. 
Cholecystectomy was performed and gallbladder was 
referred for histopathologic examination. 
Grossly, the gallbladder measured 8.5x4.5 cm. On 
the cut surface, there was a marked whitish mural 
thickening measuring up to 3 cm in diameter. Th ere 
were collections of bile in the lumen and a yellow-
ish gallstone measuring up to 2 cm in diameter. Th e 
cystic duct was dilated and partially occluded with a 
white to yellowish tumor. 
Microscopic examination showed an infi ltrating 
carcinoma with individual signet-ring cells compris-
ing more than 90% of the tumor (Fig. 1A). Th e cells 
had abundant intracellular mucin and were seen in 
small clusters and diff use sheets (Fig. 1B). No areas 
of conventional adenocarcinoma were seen. Tumor 
cells were present in all layers of the gallbladder wall. 
Th ey were alcian-PAS positive and diastase resistant 
(Fig. 1C). Th ere was lymphatic and vascular, as well as 
Fig. 1. (A) Microscopic examination showed an infi ltrating carcinoma with individual signet-ring cells comprising 
more than 90% of the tumor (HE stain, scale bar is 300 μm); (B) the cells had abundant intracellular mucin and were 
seen in small clusters and diff use sheets (HE stain, scale bar is 60 μm); (C) tumor cells were alcian-PAS positive and 
diastase resistant (alcian – PAS stain, scale bar is 100 μm); and (D) immunohistochemically, tumor cells were positive 
for cytokeratin AE1/AE3 (cytokeratin AE1/AE3 stain, scale bar is 100 μm).
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perineural invasion. Immunohistochemically, tumor 
cells were positive for cytokeratin (CK) AE1/AE3 
(Fig. 1D), CK7, CK8, CK18, CK20, carcinoembry-
onic antigen, epithelial membrane antigen, p53 and 
MUC1. Cytokeratin 5/6, MUC-2, neuron specifi c 
enolase, chromogranin A, synaptophysin, progester-
one and estrogen were negative. 
Th e diagnosis of SRCC of the gallbladder was es-
tablished. On postoperative day 4, the patient died. 
Th e exact cause of death was not established because 
autopsy was not performed.
Discussion
To our knowledge, we report the fourth case of 
SRCC of the gallbladder. Krunic et al.2 have reported 
one case of disseminated gallbladder SRCC in a 38-
year-old man who received radiotherapy and chemo-
therapy. Th e patient was alive twenty months after 
the original diagnosis. Th e second case, reported by 
Karabulut et al.3, was a 76-year-old male patient with 
SRCC who died within three months of the diagnosis 
despite radical surgery and chemotherapy. Th e third 
case was a patient with SRCC and anomalous pan-
creaticobiliary ductal union. It has been reported in 
Japanese language by Yamauchi et al.4 and we have no 
additional information on this case.
Signet-ring cell carcinoma can arise from virtu-
ally any organ. However, more than 90% of SRCC 
cases in humans arise from the stomach, breast and 
colon5-7. Because of its rarity, gallbladder SRCC may 
be misinterpreted as a metastatic carcinoma from the 
aforementioned organs. 
A variety of immunohistochemical markers have 
been employed to distinguish SRCC from the stom-
ach, breast and colon. A panel of immunohistochem-
istry markers can be used to facilitate the diagnosis 
of metastatic SRCC from these organs7. However, 
before performing immunohistochemical staining, 
obtaining a complete clinical history is the fi rst step 
in the evaluation of the possible metastatic SRCC. 
Th e most frequently used markers are CK7, CK20, 
MUC1, MUC2 and estrogen. Th e majority of gastric 
SRCC show CK7, CK20 and MUC2 positivity but 
are MUC1 negative. Breast SRCC are mostly CK7, 
MUC1 and estrogen positive but CK20 negative, 
whereas colon SRCC are usually CK20 and MUC 2 
positive and CK7 and MUC1 negative5-7. 
In the case presented, clinical data and growth 
pattern indicated a primary gallbladder carcinoma. 
Furthermore, the immunoprofi le was consistent with 
conventional biliary-type adenocarcinoma. It was dif-
ferent from the immunoprofi le of the stomach, breast 
and colon SRCC, thus providing additional support 
for its gallbladder origin8-10.
A condition that could be misdiagnosed as gall-
bladder SRCC is the accumulation of non-neoplastic 
signet-ring cells in the gallbladder mucosa11-13. Four 
cases of benign signet-ring cell aggregates in the gall-
bladder mucosa associated with focal ulceration and 
infl ammation have been described by Michal et al.11, 
Suri et al.12 and Raggazi et al.13. Th e underlying bio-
logical mechanism is still unclear. Suri et al.12 ruled 
out the hypothesis of metaplastic genesis because 
signet-ring cells are not part of the normal adult cell 
population. Michal et al.11 attributed the presence of 
signet-ring cells in the gallbladder to the combined 
eff ect of mucosal necrosis and ulceration. Ragazzi et 
al.13 suggest that in mucin-producing mucosa, focal 
ischemia could cause sloughing and disaggregation of 
the cells, leading to signet-ring changes. 
Th e main morphological features that allow for 
diff erentiation between non-neoplastic and neoplastic 
signet-ring cells are the confi nement of non-neoplastic 
cells to the mucosal surface or glandular lumina and 
their lack of cellular atypia, nuclear hyperchromasia, 
prominent nucleoli or mitoses14. Furthermore, non-
neoplastic signet-ring cells are usually accompanied by 
prominent infl ammatory and necrotizing changes14,15. 
In dubious cases, immunohistochemistry could play an 
important role. Comparative analysis done by Wang 
et al.14 showed that non-neoplastic signet-ring cells, in 
contrast to neoplastic cells, exhibit E-cadherin expres-
sion, no cell proliferation, and no p53 mutation. 
In our case, clinical data, histologic fi ndings and 
immunohistochemistry ruled out the possibility of me-
tastasis and non-neoplastic signet-ring cell changes.  
In conclusion, the incidence of gallbladder signet-
ring cell carcinoma is very low. Th erefore, it is impor-
tant to rule out the possibility of metastasis from other 
organs such as stomach, breast and colon. Further-
more, the occurrence of benign, clinically insignifi cant 
signet-ring cell changes of gallbladder mucosa could 
represent a potential diagnostic pitfall, especially in 
biopsy specimens, which can lead to overdiagnosis 
and result in malpractice issues. 
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Sažetak
SLUČAJ KARCINOMA STANICA PRSTENA PEČATNJAKA ŽUČNOG MJEHURA: 
IMUNOHISTOKEMIJA I DIFERENCIJALNA DIJAGNOSTIKA
I. Pavić, Z. Marušić, A. Mijić, D. Baličević, B. Krušlin i D. Tomas
Morfološki spektar karcinoma žučnog mjehura širok je i raznolik. Većina tumora su tubularni adenokarcinomi. Postoje 
neki tumori neobične morfologije koje je teže klasifi cirati zbog njihove rijetkosti. Jedan od takvih tumora je karcinom sta-
nica prstena pečatnjaka, visoko agresivna varijanta adenokarcinoma žučnjaka koja proizvodi sluz, a pretežito je ili isključivo 
sastavljena od stanica tipa prstena pečatnjaka. Histološki, ovi su tumori slični svojim pandanima u drugim organima kao 
što su želudac, debelo crijevo i dojka te ih se ne bi smjelo pogrešno interpretirati kao metastatske karcinome iz spomenutih 
organa. Literatura na temu ovoga tipa karcinoma je rijetka i o njemu se malo zna. Našli smo samo 3 prethodno objavljena 
slučaja ovoga karcinoma. U članku se prikazuje slučaj 86-godišnje žene s karcinomom stanica prstena pečatnjaka žučnjaka 
i raspravlja o potencijalnim dijagnostičkim dvojbama i mogućim pogreškama.
Ključne riječi: Karcinom stanica prstena pečatnjaka; Novotvorine žučnjaka – dijagnostika; Novotvorine žučnjaka – pa-
tologija; Prikaz slučaja
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